Table 1. Overview of Results of Silicone Presence Inside and Outside the Capsule, Including Lymph Nodes, and Presence of ALCL.
| Characteristic | No. (%) (N = 389) |
|---|---|
| Resected capsules | 365 (93.8) |
| Only lymph nodes examined | 24 (6.2) |
| Silicones in tissues surrounding the capsule or in lymph nodesa | 337 (86.6) |
| Silicones inside capsule only | 47 (12.1) |
| No silicones detected | 5 (1.3) |
| Cohesive silicone gel breast implantsb | 46 (11.8) |
| Silicones outside capsule | 38 (82.6) |
| Silicones inside capsule only | 6 (13.0) |
| No silicones detected | 2 (4.3) |
| Lymph nodes examined | 10 (21.7) |
| Silicones in lymph nodes | 10 (100) |
| Noncohesive silicone gel or unknown type of breast implants | 343 (88.2) |
| Silicones outside capsule or in lymph nodes | 299 (87.2) |
| Silicones inside capsule only | 41 (12.0) |
| No silicones detected | 3 (0.9) |
| Lymph nodes examineda | 31 (9.0) |
| Silicones in lymph nodes | 30 (96.8) |
| No silicones in lymph nodes | 1 (3.2) |
| ALCL | 6 (1.5) |
| Silicones outside capsule | 1 (16.7) |
Abbreviation: ALCL, anaplastic large cell lymphoma.
a
Including 24 women with only lymph nodes examined.
b
Including 31 women with confirmed clinical data for cohesive gel breast implant, with 15 cohesive gel implants determined based on age and year of histological report.